Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1776985 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $92.95Day +0.54%1Y −16.6%Off 52W high −25.0%Vol (1Y) 41.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,703 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.9% of sh out |
| Days to cover2.9d |
| 13F net flow (QoQ)−1.16% |
| Top-10 13F concentration62.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)€2.87B |
| Earnings (TTM)-€1.14B |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (EUR). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−2.4% |
| 1Y−16.6% |
| 3Y−14.6% |
| 5Y−69.6% |
| Since incept. (ann.)+32.2% |
Total return through 2026-07-29 · series begins 2019-10-10. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)41.7% |
| Ann. volatility (3Y)45.0% |
| Sharpe (1Y)−0.26 |
| Sharpe (3Y)0.12 |
| Max drawdown (1Y)−29.7% |
| Max drawdown (3Y)−37.4% |
| Beta (3Y vs SPY)1.25 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.9M | $520M | 2.32% | −22.7% |
| FMR LLC | 5.7M | $507M | 2.26% | −3.8% |
| PRIMECAP MANAGEMENT CO/CA/ | 3.8M | $337M | 1.50% | −0.2% |
| FLOSSBACH VON STORCH SE | 3.7M | $327M | 1.46% | −12.3% |
| Dodge & Cox | 3.7M | $327M | 1.45% | +1.7% |
| BlackRock, Inc. | 1.7M | $147M | 0.66% | +43.8% |
| BNP PARIBAS FINANCIAL MARKETS | 1.7M | $147M | 0.65% | +4.7% |
| Temasek Holdings (Private) Ltd | 1.5M | $134M | 0.60% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for BNTX.
